Business Description
Founded in 1915 and based in Valby, Denmark, H. Lundbeck A/S is a pharmaceutical company focused entirely on brain health, developing and selling treatments for conditions such as depression, schizophrenia, epilepsy, migraine, and Parkinson's disease across Europe, the United States, and beyond. The company markets a broad range of established medicines while also running an active pipeline of new treatments at various stages of clinical testing. Lundbeck also works with external partners, including a research collaboration with Contera Pharma aimed at building new therapies for serious neurological conditions.